Coherus Oncology, Inc.
US ˙ NasdaqGM ˙ US19249H1032

SecurityCHRS / Coherus Oncology, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership2,064,326 shares
Ownership 1.85%
State Street Corp ownership in CHRS / Coherus Oncology, Inc.

2024-01-22 - State Street Corp has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,064,326 shares of Coherus Oncology, Inc. (US:CHRS). This represents 1.85 percent ownership of the company. In their previous filing dated 2023-02-03 , State Street Corp had reported owning 6,785,982 shares, indicating a decrease of -69.58 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2024-01-22 2024-01-22 13G/A 6,785,982 2,064,326 -69.58 1.85 -78.78
2023-02-03 2023-02-03 13G/A 3,821,120 6,785,982 77.59 8.72 75.10
2022-02-09 2022-02-09 13G/A 4,619,050 3,821,120 -17.27 4.98 -22.31
2021-02-08 2021-02-08 13G 4,619,050 6.41

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F COHERUS ONCOLOGY COM 19249H103 2,325,859 102,463 4.61 3,931 24.49 0.0001
2026-02-13 2025-12-31 13F COHERUS ONCOLOGY COM 19249H103 2,223,396 20 0.00 3,157 -13.41 0.0001
2025-11-14 2025-09-30 13F COHERUS ONCOLOGY COM 19249H103 2,223,376 4,843 0.22 3,646 124.78 0.0001
2025-08-14 2025-06-30 13F COHERUS ONCOLOGY COM 19249H103 2,218,533 -8,318 -0.37 1,622 -9.74 0.0001
2025-05-15 2025-03-31 13F COHERUS BIOSCIENCES COM 19249H103 2,226,851 49,820 2.29 1,797 -40.18 0.0001
2025-02-14 2024-12-31 13F COHERUS BIOSCIENCES COM 19249H103 2,177,031 150,699 7.44 3,004 42.57 0.0001
2024-11-14 2024-09-30 13F COHERUS BIOSCIENCES COM 19249H103 2,026,332 13,579 0.67 2,107 -39.49 0.0001
2024-08-14 2024-06-30 13F COHERUS BIOSCIENCES COM 19249H103 2,012,753 17,015 0.85 3,482 -26.99 0.0002
2024-05-15 2024-03-31 13F COHERUS BIOSCIENCES COM 19249H103 1,995,738 -68,588 -3.32 4,770 -30.62 0.0002
2024-02-14 2023-12-31 13F COHERUS BIOSCIENCES COM 19249H103 2,064,326 -6,726,601 -76.52 6,874 -79.09 0.0003
2023-11-14 2023-09-30 13F COHERUS BIOSCIENCES COM 19249H103 8,790,927 6,238,667 244.44 32,878 201.69 0.0018
2023-08-14 2023-06-30 13F COHERUS BIOSCIENCES COM 19249H103 2,552,260 -3,545,323 -58.14 10,898 -73.87 0.0006
2023-05-15 2023-03-31 13F COHERUS BIOSCIENCES COM 19249H103 6,097,583 -688,399 -10.14 41,707 -22.40 0.0024
2023-05-15 2022-12-31 13F/A-99 COHERUS BIOSCIENCES COM 19249H103 6,785,982 1,680,211 32.91 53,745 9.53 0.0032
2023-05-15 2022-12-31 13F COHERUS BIOSCIENCES COM 19249H103 6,785,982 1,680,211 53,745 0.0032
2022-11-15 2022-09-30 13F COHERUS BIOSCIENCES COM 19249H103 5,105,771 -1,277,332 -20.01 49,066 6.17 0.0031
2022-08-15 2022-06-30 13F COHERUS BIOSCIENCES COM 19249H103 6,383,103 1,218,951 23.60 46,214 -30.68 0.0028
2022-05-16 2022-03-31 13F COHERUS BIOSCIENCES COM 19249H103 5,164,152 1,343,032 35.15 66,669 9.32 0.0033
2022-02-14 2021-12-31 13F COHERUS BIOSCIENCES COM 19249H103 3,821,120 -212,586 -5.27 60,985 -5.92 0.0029
2021-11-15 2021-09-30 13F COHERUS BIOSCIENCES COM 19249H103 4,033,706 -1,040,435 -20.50 64,822 -7.63 0.0034
2021-08-16 2021-06-30 13F COHERUS BIOSCIENCES COM 19249H103 5,074,141 241,760 5.00 70,175 -0.60 0.0037
2021-07-09 2021-03-31 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 4,832,381 213,331 4.62 70,601 -12.06 0.0040
2021-05-17 2021-03-31 13F COHERUS BIOSCIENCES COM 19249H103 4,832,381 213,331 70,601 0.0040
2021-02-16 2020-12-31 13F COHERUS BIOSCIENCES COM 19249H103 4,619,050 324,644 7.56 80,279 1.93 0.0049
2020-11-10 2020-09-30 13F COHERUS BIOSCIENCES COM 19249H103 4,294,406 -881,740 -17.03 78,759 -14.81 0.0054
2020-08-14 2020-06-30 13F COHERUS BIOSCIENCES COM 19249H103 5,176,146 1,673,152 47.76 92,446 62.70 0.0067
2020-06-19 2020-03-31 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 3,502,994 16,517 0.47 56,819 -9.49 0.0050
2020-05-11 2020-03-31 13F COHERUS BIOSCIENCES COM 19249H103 3,502,994 16,517 56,819 4,989.8523
2020-02-06 2019-12-31 13F COHERUS BIOSCIENCES COM 19249H103 3,486,477 702,638 25.24 62,774 11.30 0.0043
2019-11-14 2019-09-30 13F COHERUS BIOSCIENCES COM 19249H103 2,783,839 342,885 14.05 56,401 4.55 0.0042
2019-08-14 2019-06-30 13F COHERUS BIOSCIENCES COM 19249H103 2,440,954 214,286 9.62 53,945 77.61 0.0040
2019-05-15 2019-03-31 13F COHERUS BIOSCIENCES COM 19249H103 2,226,668 -417,455 -15.79 30,372 26.93 0.0024
2019-02-12 2018-12-31 13F COHERUS BIOSCIENCES COM 19249H103 2,644,123 464,506 21.31 23,929 -33.47 0.0022
2018-11-09 2018-09-30 13F COHERUS BIOSCIENCES Common equity shares 19249H103 2,179,617 73,013 3.47 35,967 21.93 0.0028
2018-08-14 2018-06-30 13F COHERUS BIOSCIENCES Common equity shares 19249H103 2,106,604 187,305 9.76 29,499 39.09 0.0025
2018-05-15 2018-03-31 13F COHERUS BIOSCIENCES Common equity shares 19249H103 1,919,299 -185,211 -8.80 21,209 14.53 0.0018
2018-02-14 2017-12-31 13F COHERUS BIOSCIENCES Common equity shares 19249H103 2,104,510 228,407 12.17 18,519 -26.06 0.0015
2017-11-14 2017-09-30 13F COHERUS BIOSCIENCES Common equity shares 19249H103 1,876,103 459,531 32.44 25,047 23.21 0.0022
2017-08-14 2017-06-30 13F COHERUS BIOSCIENCES Common equity shares 19249H103 1,416,572 298,986 26.75 20,329 -14.00 0.0018
2017-05-15 2017-03-31 13F COHERUS BIOSCIENCES Common equity shares 19249H103 1,117,586 167,111 17.58 23,638 -11.65 0.0021
2017-02-09 2016-12-31 13F COHERUS BIOSCIENCES Common equity shares 19249H103 950,475 148,768 18.56 26,754 24.63 0.0025
2017-01-13 2016-09-30 13F/A-1 COHERUS BIOSCIENCES Common equity shares 19249H103 801,707 342,829 74.71 21,466 176.94 0.0022
2016-11-14 2016-09-30 13F COHERUS BIOSCIENCES Common equity shares 19249H103 801,707 21,466
2016-08-12 2016-06-30 13F COHERUS BIOSCIENCES Common equity shares 19249H103 458,878 85,658 22.95 7,751 -2.20 0.0008
2016-05-20 2016-03-31 13F/A-1 COHERUS BIOSCIENCES Common equity shares 19249H103 373,220 6,554 1.79 7,925 -5.85 0.0009
2016-05-12 2016-03-31 13F COHERUS BIOSCIENCES Common equity shares 19249H103 373,220 7,925
2016-02-16 2015-12-31 13F COHERUS BIOSCIENCES Common equity shares 19249H103 366,666 9,899 2.77 8,417 17.77 0.0009
2015-11-16 2015-09-30 13F COHERUS BIOSCIENCES Common equity shares 19249H103 356,767 92,885 35.20 7,147 -6.29 0.0008
2015-08-13 2015-06-30 13F COHERUS BIOSCIENCES Common equity shares 19249H103 263,882 183,075 226.56 7,627 208.91 0.0008
2015-05-15 2015-03-31 13F COHERUS BIOSCIENCES Common equity shares 19249H103 80,807 47,929 145.78 2,469 359.78 0.0003
2015-02-11 2014-12-31 13F COHERUS BIOSCIENCES Common equity shares 19249H103 32,878 32,878 537 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.